Google
Trusted Resources: News & Events
Latest announcements and gatherings
Sickle Cell Disease and Cold Weather: Dos and Don’ts
In the United States today, one of every 400 African-American children and one in every 1,250 Hispanic children are born with sickle cell disease, a debilitating, painful condition. Patients with sickle cell disease suffer from abnormally shaped, rigid and adhesive red blood cells. These abnormal cells “close off” blood vessels and cause recurring, painful episodes called “sickle cell crises.” An individual with sickle cell disease can develop a crisis at any time – the pain can last for days or even weeks and is frequently severe enough to require hospitalization.
These painful events associated with SCD can be more severe and occur more frequently in cold weather.
+myBinderRelated Content
-
Providing Expert Care for Pregnant Sickle Cell Patienthttps://www.youtube.com/watch?v=rTebitxq...
-
A Comparison of an Individualized and Weight-Based Opioid Protocols for the Treatment of Vaso-Occlusive Episodes in ...Introduction: Vaso-occlusive episodes ar...
-
Prospective study of sickle cell trait and venous thromboembolism incidenceBACKGROUND: Sickle cell trait may incre...
-
New Guidelines for Managing Sickle Cell Disease Presented at ACP Internal Medicine MeetingNew guidelines for therapeutic strategie...
-
New treatment plan leads to better pain control for acute sickle cell crisisThere’s new hope for the 70,000 to 80,...
-
Phase 1 trial to test under-the-skin injection of sevuparin in sickle cell patientsModus Therapeutics is going to launch ...
-
Black Americans With Sickle Cell Trait At Increased Risk Of Kidney DiseaseAfrican Americans with sickle cell trait...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.